The number of reported adverse events following COVID vaccines continues to climb, according to data released today by the Centers for Disease Control and Prevention (CDC). The data comes directly from reports submitted to the Vaccine Adverse.
Published: Jun 03, 2021 By Alex Keown
180 Life Sciences Russell T. Ray and Teresa DeLuca were appointed to the board of directors of 180 Life Sciences. Ray was formerly Managing Director and co-Head of Global Health Care at Credit Suisse First Boston Corporation. More recently, Ray was a Partner and Senior Advisor to HLM Venture Partners, a health care-focused venture capital firm. He currently serves on the board of directors of Merrimack Pharmaceuticals, Inc. DeLuca comes to 180 Life Sciences as both a public independent board director and former senior executive Chief Medical Officer. Her most recent role was at Columbia University as Managing Director of NY Life Science Venture Fund.
Novel Text Messaging Program Boosts ADHD Treatment Adherence medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
John And Willie Mae Helm Scholarship Fund Available For Los Alamos And Rio Arriba Medical Students ladailypost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ladailypost.com Daily Mail and Mail on Sunday newspapers.